GALE Galenica AG

Galenica successfully places a bond of over CHF 100 million

Galenica AG / Key word(s): Bond
Galenica successfully places a bond of over CHF 100 million

16.04.2024 / 18:05 CET/CEST

Press release

Today, Galenica successfully placed a fixed rate bond of over CHF 100 million.

The bond has a term of 7 years and an annual coupon of 1.65%. The proceeds from the transaction will be used for general corporate purposes. With this new bond, Galenica is reducing its short-term financial liabilities and securing its long-term financing. The term until 2031 ideally complements the terms of the outstanding bonds from 2026 (CHF 180 million, coupon 1.0%) and 2029 (CHF 240 million, coupon 2.35%).   

 

UBS and Zürcher Kantonalbank are joint lead manager for this issue. An application for admission to trading on the SIX Swiss Exchange for the bond is being made.

Dates for the diary

23 May 2024 Galenica Group sales update
6 August 2024   Galenica Group half-year results 2024
24 October 2024 Galenica Group sales update

 

For further information, please contact:

 

Media Relations:
E-Mail:
Tel. 7		 Investor Relations:
E-Mail:
Tel. 1

Welcome to the Galenica network!
Our ambition is to meet the needs of patients and customers in the Swiss healthcare market in a seamless, efficient and personalised way. To achieve this, we operate the Galenica network with over 20 Business Units, the strongest partners in the Swiss healthcare market. We offer fully integrated solutions both for customers and patients as well as for pharmacies, drugstores, medical practices, hospitals, retirement and nursing homes, home care providers, wholesalers, pharmaceutical companies, health insurance funds and other partners.
Galenica is listed on the Swiss Stock Exchange (SIX Swiss Exchange, GALE, security number 36,067,446). Additional information concerning Galenica can be found at .


End of Media Release
Language: English
Company: Galenica AG
Untermattweg 8
3027 Bern
Switzerland
Phone: 11
E-mail:
Internet:
ISIN: CH0360674466
Listed: SIX Swiss Exchange
EQS News ID: 1881579

 
End of News EQS News Service

1881579  16.04.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1881579&application_name=news&site_id=research_pool
EN
16/04/2024

Underlying

GALEGalenica AG

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Galenica AG

Christophe Chaput
  • Christophe Chaput
EKI EKINOPS SA
KOF KAUFMAN & BROAD SA
ROYAL VOPAK NV
BRAV BRAVIDA HOLDING AB
GALE GALENICA AG
WINE PURCARI WINERIES PCL
07/11/25 July 11, 2025 1 EN
Christophe Chaput
  • Christophe Chaput
EKI EKINOPS SA
KOF KAUFMAN & BROAD SA
ROYAL VOPAK NV
BRAV BRAVIDA HOLDING AB
GALE GALENICA AG
WINE PURCARI WINERIES PCL
07/11/25 July 11, 2025 1 FR
Juan Ros-Padilla
  • Juan Ros-Padilla
GALE GALENICA AG

Galenica : Quality comes at a price

Galenica is a well-managed and resilient company that has an unassailable dominance of the Swiss pharma distribution and related services. Over the years the company has earned a quality compounder reputation (+12% annualised TRS since IPO) which is reflected in its 20% average premium vs the SMI. Going forward we expect the company to keep a robust TRS profile of 8-9% p.a. (ex M&A). We initiate our coverage with a Neutral rating as its current premium (30%) and the limited upside to our target...

07/11/25 July 11, 2025 1 EN
Free Trial
GALE GALENICA AG

Galenica AG: 1 director

A director at Galenica AG sold 3,000 shares at 83.305CHF and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...

04/25/25 April 25, 2025 1 EN
 PRESS RELEASE
Free
GALE GALENICA AG

Galenica nomme Nadine Balkanyi-Nordmann au Conseil d’administration

Galenica AG / Mot-clé(s) : Personnel Galenica nomme Nadine Balkanyi-Nordmann au Conseil d’administration 23.01.2025 / 07:00 CET/CEST Communiqué de presse Nadine Balkanyi-Nordmann, experte expérimentée en droit, compliance et gouvernance, sera proposée à l’élection au Conseil d’administration lors de la prochaine Assemblée générale du Groupe Galenica. Lors de la prochaine Assemblée générale du 10 avril 2025, il sera proposé aux actionnaires d’élire un nouveau membre au Conseil d’administration de Galenica: Nadine Balkanyi-Nordmann (1972), personnalité dirigeante reconnue et experte...

January 23, 2025 1 FR

ResearchPool Subscriptions

Get the most out of your insights

Get in touch